Promoter hypermethylation of the cyclin-dependent kinase inhibitor (CDKI) gene p21WAF1/CIP1/SDI1 is rare in various lymphomas and carcinomas

This publication has 8 references indexed in Scilit:

• Methylation Analysis of Cyclin-Dependent Kinase Inhibitor Genes in Primary Gastrointestinal Lymphomas
  Laboratory Investigation, 2003
• Methylation of Adjacent CpG Sites Affects Sp1/Sp3 Binding and Activity in the p21^Cip1 Promoter
  Molecular and Cellular Biology, 2003
• Lack of p21CIP1 DNA methylation in acute lymphocytic leukemia
  Blood, 2002
• Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells
  Human Molecular Genetics, 2002
• Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors
  Oncogene, 2002
• 5′ CpG island hypermethylation is associated with transcriptional silencing of the p21CIP1/WAF1/SDI1 gene and confers poor prognosis in acute lymphoblastic leukemia
  Blood, 2002
• Heterogeneous Methylation and Deletion Patterns of the INK4a/ARF Locus Within Prostate Carcinomas
  The American Journal of Pathology, 2002
• Histone deacetylase inhibitor selectively induces p21 ^WAF1 expression and gene-associated histone acetylation
  Proceedings of the National Academy of Sciences, 2000